Loading
PI
PaxMedica, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by TardiMed Sciences LLC, was filed 01 Sept 2022.
PaxMedica, Inc.: what insiders have been doing
Every trade that managers of PaxMedica, Inc. disclose to SEC (Form 4) is tracked on this page. The company sits in the Health Care sector. No insider at PaxMedica, Inc. has published a filing in the past twelve months. The most recent one dates from 14 March 2024.
Looking back to 2022, when coverage begins, insiders filed 1 purchase and 50 sales.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
86
Thresholds
n/a
Buy Volume
€497,503
1 ops. · all time
Sell Volume
€496,626
50 ops. · all time
Since the insiders bought
- -91.6%Entry US$87.89 · Close at T+365 US$7.39
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2023FY ended December 2023 · cache
US$0.00
Analyst consensus
Income statement
EBITDA-US$18.3M
Net income-US$18.3M0.0% margin
Valuation
PER (trailing)0.0x
Beta-31.82
Balance sheet & cash
Total debtUS$173.5k
Free Cash Flow-US$10.8M
Profitability & ownership
ROA-370.4%
% institutions0.2%
Last declaration on 14 March 2024
Declarations86 total
4,904 shares@ US$0.692.2% of flowCommon StockSEC:0001104659-24-034552:0
992 shares@ US$0.6925.3% of flowCommon StockSEC:0001104659-24-034545:0
2,927 shares@ US$0.691.6% of flowCommon StockSEC:0001104659-24-034557:0
1,452 shares@ US$0.6983.8% of flowCommon StockSEC:0001104659-24-034548:0
207 shares@ US$0.691.8% of flowCommon StockSEC:0001104659-24-034546:0
3,356 shares@ US$0.6955.4% of flowCommon StockSEC:0001104659-24-034555:0
604 shares@ US$0.691.8% of flowCommon StockSEC:0001104659-24-034550:0
291 shares@ US$0.65916.2% of flowCommon StockSEC:0001104659-24-027112:0
243 shares@ US$0.6593.9% of flowCommon StockSEC:0001104659-24-027107:0
811 shares@ US$0.480.0% of flowCommon StockSEC:0001104659-24-008960:0
27 shares@ US$0.480.2% of flowCommon StockSEC:0001104659-24-008886:0
78 shares@ US$0.480.2% of flowCommon StockSEC:0001104659-24-008888:0
97 shares@ US$0.762.7% of flowCommon StockSEC:0001104659-24-008885:0
372 shares@ US$0.470.1% of flowCommon StockSEC:0001104659-24-008883:0
162 shares@ US$1.02620.1% of flowCommon StockSEC:0001062993-23-021596:0
359 shares@ US$1.03030.2% of flowCommon StockSEC:0001062993-23-021593:0
185 shares@ US$1.02640.3% of flowCommon StockSEC:0001062993-23-021595:0
35 shares@ US$1.02650.2% of flowCommon StockSEC:0001062993-23-021594:0
12 shares@ US$1.0250.2% of flowCommon StockSEC:0001062993-23-021597:0
971 shares@ US$1.7540.7% of flowCommon StockSEC:0001062993-23-021357:0
570 shares@ US$0.18951.4% of flowCommon StockSEC:0001062993-23-019821:0
1,679 shares@ US$0.1891.4% of flowCommon StockSEC:0001062993-23-019820:0
16,301 shares@ US$0.18482.1% of flowCommon StockSEC:0001062993-23-019824:0
9,175 shares@ US$0.18972.6% of flowCommon StockSEC:0001062993-23-019823:0
8,049 shares@ US$0.18941.2% of flowCommon StockSEC:0001062993-23-019819:0
25 of 86 declarations
About PaxMedica, Inc.
PaxMedica, Inc. is a company focused on developing treatments for neurodevelopmental disorders. It is listed on the XNAS market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
